251 related articles for article (PubMed ID: 37338165)
21. Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.
Aziz MT; Good BL; Lowe DK
Ann Pharmacother; 2014 May; 48(5):626-32. PubMed ID: 24577146
[TBL] [Abstract][Full Text] [Related]
22. Pronociceptive Roles of Schwann Cell-Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy.
Koyanagi M; Imai S; Matsumoto M; Iguma Y; Kawaguchi-Sakita N; Kotake T; Iwamitsu Y; Ntogwa M; Hiraiwa R; Nagayasu K; Saigo M; Ogihara T; Yonezawa A; Omura T; Nakagawa S; Nakagawa T; Matsubara K
Cancer Res; 2021 Apr; 81(8):2207-2219. PubMed ID: 33608316
[TBL] [Abstract][Full Text] [Related]
23. Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review.
Flatters SJL; Dougherty PM; Colvin LA
Br J Anaesth; 2017 Oct; 119(4):737-749. PubMed ID: 29121279
[TBL] [Abstract][Full Text] [Related]
24. Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study.
Yokoyama S; Nakagawa C; Hosomi K
Support Care Cancer; 2022 Feb; 30(2):1765-1773. PubMed ID: 34595605
[TBL] [Abstract][Full Text] [Related]
25. [Chemotherapy-induced peripheral neuropathy and neuropathic pain].
Schuler U; Heller S
Schmerz; 2017 Aug; 31(4):413-425. PubMed ID: 28293734
[TBL] [Abstract][Full Text] [Related]
26. Analgesic and preventive effects of donepezil in animal models of chemotherapy-induced peripheral neuropathy: Involvement of spinal muscarinic acetylcholine M2 receptors.
Selvy M; Mattévi C; Dalbos C; Aissouni Y; Chapuy E; Martin PY; Collin A; Richard D; Dumontet C; Busserolles J; Condé S; Balayssac D
Biomed Pharmacother; 2022 May; 149():112915. PubMed ID: 35635358
[TBL] [Abstract][Full Text] [Related]
27. Nicotine Prevents and Reverses Paclitaxel-Induced Mechanical Allodynia in a Mouse Model of CIPN.
Kyte SL; Toma W; Bagdas D; Meade JA; Schurman LD; Lichtman AH; Chen ZJ; Del Fabbro E; Fang X; Bigbee JW; Damaj MI; Gewirtz DA
J Pharmacol Exp Ther; 2018 Jan; 364(1):110-119. PubMed ID: 29042416
[TBL] [Abstract][Full Text] [Related]
28. Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings.
Ibrahim EY; Ehrlich BE
Crit Rev Oncol Hematol; 2020 Jan; 145():102831. PubMed ID: 31783290
[TBL] [Abstract][Full Text] [Related]
29. A randomized controlled trial using surgical gloves to prevent chemotherapy-induced peripheral neuropathy by paclitaxel in breast cancer patients (AIUR trial).
Kang YJ; Yoon CI; Yang YJ; Baek JM; Kim YS; Jeon YW; Rhu J; Yi JP; Kim D; Oh SJ
BMC Cancer; 2023 Jun; 23(1):570. PubMed ID: 37340369
[TBL] [Abstract][Full Text] [Related]
30. Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.
Zhang H; Li Y; de Carvalho-Barbosa M; Kavelaars A; Heijnen CJ; Albrecht PJ; Dougherty PM
J Pain; 2016 Jul; 17(7):775-86. PubMed ID: 26979998
[TBL] [Abstract][Full Text] [Related]
31. Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan.
Hiramoto S; Asano H; Miyamoto T; Takegami M; Kawabata A
PLoS One; 2021; 16(12):e0261473. PubMed ID: 34972132
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
Albany C; Dockter T; Wolfe E; Le-Rademacher J; Wagner-Johnston N; Einhorn L; Lafky JM; Smith E; Pachman D; Staff N; Ma C; Loprinzi CL; Costello BA
Support Care Cancer; 2021 Feb; 29(2):833-840. PubMed ID: 32500206
[TBL] [Abstract][Full Text] [Related]
33. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.
Bao T; Seidman AD; Piulson L; Vertosick E; Chen X; Vickers AJ; Blinder VS; Zhi WI; Li Q; Vahdat LT; Dickler MN; Robson ME; Mao JJ
Eur J Cancer; 2018 Sep; 101():12-19. PubMed ID: 30007894
[TBL] [Abstract][Full Text] [Related]
34. Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats.
Yamamoto S; Kawashiri T; Higuchi H; Tsutsumi K; Ushio S; Kaname T; Shirahama M; Egashira N
J Pharmacol Sci; 2015 Sep; 129(1):43-50. PubMed ID: 26362518
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy-induced peripheral neuropathy: prevention and treatment.
Pachman DR; Barton DL; Watson JC; Loprinzi CL
Clin Pharmacol Ther; 2011 Sep; 90(3):377-87. PubMed ID: 21814197
[TBL] [Abstract][Full Text] [Related]
36. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.
Smith EM; Pang H; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Fadul CE; Knox C; Le-Lindqwister N; Gilman PB; Shapiro CL;
JAMA; 2013 Apr; 309(13):1359-67. PubMed ID: 23549581
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
Kachrani R; Santana A; Rogala B; Pawasauskas J
J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
[TBL] [Abstract][Full Text] [Related]
38. Comparative analgesic efficacy of pregabalin administered according to either a prevention protocol or an intervention protocol in rats with cisplatin-induced peripheral neuropathy.
Han FY; Kuo A; Nicholson JR; Corradinni L; Smith MT
Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1067-1075. PubMed ID: 29781509
[TBL] [Abstract][Full Text] [Related]
39. Tamoxifen suppresses paclitaxel-, vincristine-, and bortezomib-induced neuropathy via inhibition of the protein kinase C/extracellular signal-regulated kinase pathway.
Tsubaki M; Takeda T; Matsumoto M; Kato N; Yasuhara S; Koumoto YI; Imano M; Satou T; Nishida S
Tumour Biol; 2018 Oct; 40(10):1010428318808670. PubMed ID: 30360692
[TBL] [Abstract][Full Text] [Related]
40. Role of pattern recognition receptors in chemotherapy-induced neuropathic pain.
Araldi D; Khomula EV; Bonet IJM; Bogen O; Green PG; Levine JD
Brain; 2024 Mar; 147(3):1025-1042. PubMed ID: 37787114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
